Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists.
Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol. 2009 Jan; 123(1):124-130.e1.